Clinical Research Directory
Browse clinical research sites, groups, and studies.
Remote Sputum Collection in Cystic Fibrosis
Sponsor: University of Pennsylvania
Summary
Elexacaftor/Tezacaftor/Ivacaftor or Trikafta improves lung health in people with cystic fibrosis (CF), including decreased cough and mucous production. Diagnosing lung infections has become more challenging due to the decrease in sputum and rise of telehealth services. While the option of collecting sputum samples at home and sending them by mail may be feasible, uncertainty remains about how the collection of samples outside of clinic and delays in testing while in the mail impact infection detection. This study will compare bacterial cultures using sputum samples collected at home versus samples collected in clinic (saline-induced sputum and throat swab). This study seeks to shed light on how valuable home collected samples can be and help us better understand the usefulness of home-collected sputum samples for both clinical and research purposes.
Official title: Remote Sputum Collection in Adults With Cystic Fibrosis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2025-01-15
Completion Date
2028-06-30
Last Updated
2025-10-01
Healthy Volunteers
No
Conditions
Locations (3)
National Jewish Health
Denver, Colorado, United States
Johns Hopkins University
Baltimore, Maryland, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States